Licensed Bulk Medicines

{
  "id": "016383-2023",
  "tag": [
    "planning"
  ],
  "date": "2023-06-09T10:24:50+01:00",
  "ocid": "ocds-h6vhtk-03d4f5",
  "buyer": {
    "id": "GB-FTS-1383",
    "name": "Velindre NHS Trust, NHS Wales Shared Services Partnership — Procurement Services (on behalf of All Wales LHB's and Trusts)"
  },
  "tender": {
    "id": "ocds-h6vhtk-03d4f5",
    "lots": [
      {
        "id": "1",
        "status": "planned",
        "description": "We are interested in buying the following list of products, in licensed bulk containers of up to the sizes noted below, to be available within a 5 year timeframe. We consider the availability in licensed bulk presentation to be a significant market advantage and are willing to consider entering contracts for supply with suppliers who can meet this presentation requirement for these products.\nEstimated value in the Wales market of this list is  £42,317,736.61 p/a at current prices.\nThe list is not exhaustive, and we are willing to consider other generic and biosimilar products if licensed bulk presentation can be offered.\nDrug,Strength,Proposed Vial Size\nARSENIC TRIOXIDE,1mg/mL,\nAZACITIDINE,25mg/mL,500mL\nBEVACIZUMAB,25mg/mL,100mL - 250mL\nBORTEZOMIB,2.5mg/mL,50mL\nCALCIUM FOLINATE,10mg/mL,1000mL\nCARBOPLATIN,10mg/mL,1000mL\nCETUXIMAB,5mg/mL,250m – 500mL\nCISPLATIN,1mg/mL,500mL - 1000mL\nCYCLOPHOSPHAMIDE,20mg/mL,500mL\nCYTARABINE,100mg/mL or 20mg/mL,250mL\nDARATUMUMAB,20mg/mL,100mL – 250mL\nDOCETAXEL,20mg/mL,250mL - 500mL\nDOXORUBICIN,2mg/mL,1000mL\nEPIRUBICIN,2mg/mL,1000mL\nETOPOSIDE,20mg/mL,500mL\nFLUCLOXACILLIN,,3000mL\nFLUOROURACIL,50mg/mL or 25mg /mL,250-500mL\nINFLIXIMAB,10mg/mL,500mL - 1000mL\nIRINOTECAN,20mg/mL,1000mL\nNIVOLUMAB,10mg/mL,250mL\nOXALIPLATIN,5mg/mL,500mL-1000mL\nPACLITAXEL,6mg/mL,1000mL\nPEMBROLIZUMAB,25mg/mL,100mL – 250mL\nPEMETREXED,25mg/mL,100mL – 250mL\nPIPERACILLIN & TAZOBACTAM,,3000mL\nRITUXIMAB,10mg/mL,500mL\nTOCILIZUMAB,20mg/mL,250mL\nTRASTUZUMAB EMTANSINE,20mg/mL,100mL - 250mL\nVEDOLIZUMAB,60mg/mL,250mL\nVITLIPID N INFANT,N/A,250mL\nPlease inform us via the contact information above if you are able to provide these products."
      }
    ],
    "items": [
      {
        "id": "1",
        "relatedLot": "1",
        "deliveryAddresses": [
          {
            "region": "UKL"
          }
        ],
        "additionalClassifications": [
          {
            "id": "33600000",
            "scheme": "CPV",
            "description": "Pharmaceutical products"
          }
        ]
      }
    ],
    "title": "Licensed Bulk Medicines",
    "value": {
      "amount": 42317736.61,
      "currency": "GBP"
    },
    "status": "planned",
    "coveredBy": [
      "GPA"
    ],
    "legalBasis": {
      "id": "32014L0024",
      "scheme": "CELEX"
    },
    "description": "We are interested in buying the following list of products, in licensed bulk containers of up to the sizes noted below, to be available within a 5 year timeframe. We consider the availability in licensed bulk presentation to be a significant market advantage and are willing to consider entering contracts for supply with suppliers who can meet this presentation requirement for these products.\nEstimated value in the Wales market of this list is  £42,317,736.61 p/a at current prices.\nThe list is not exhaustive, and we are willing to consider other generic and biosimilar products if licensed bulk presentation can be offered.\nDrug,Strength,Proposed Vial Size\nARSENIC TRIOXIDE,1mg/mL,\nAZACITIDINE,25mg/mL,500mL\nBEVACIZUMAB,25mg/mL,100mL - 250mL\nBORTEZOMIB,2.5mg/mL,50mL\nCALCIUM FOLINATE,10mg/mL,1000mL\nCARBOPLATIN,10mg/mL,1000mL\nCETUXIMAB,5mg/mL,250m – 500mL\nCISPLATIN,1mg/mL,500mL - 1000mL\nCYCLOPHOSPHAMIDE,20mg/mL,500mL\nCYTARABINE,100mg/mL or 20mg/mL,250mL\nDARATUMUMAB,20mg/mL,100mL – 250mL\nDOCETAXEL,20mg/mL,250mL - 500mL\nDOXORUBICIN,2mg/mL,1000mL\nEPIRUBICIN,2mg/mL,1000mL\nETOPOSIDE,20mg/mL,500mL\nFLUCLOXACILLIN,,3000mL\nFLUOROURACIL,50mg/mL or 25mg /mL,250-500mL\nINFLIXIMAB,10mg/mL,500mL - 1000mL\nIRINOTECAN,20mg/mL,1000mL\nNIVOLUMAB,10mg/mL,250mL\nOXALIPLATIN,5mg/mL,500mL-1000mL\nPACLITAXEL,6mg/mL,1000mL\nPEMBROLIZUMAB,25mg/mL,100mL – 250mL\nPEMETREXED,25mg/mL,100mL – 250mL\nPIPERACILLIN & TAZOBACTAM,,3000mL\nRITUXIMAB,10mg/mL,500mL\nTOCILIZUMAB,20mg/mL,250mL\nTRASTUZUMAB EMTANSINE,20mg/mL,100mL - 250mL\nVEDOLIZUMAB,60mg/mL,250mL\nVITLIPID N INFANT,N/A,250mL\nPlease inform us via the contact information above if you are able to provide these products.",
    "communication": {
      "futureNoticeDate": "2025-01-01T00:00:00Z"
    },
    "classification": {
      "id": "33600000",
      "scheme": "CPV",
      "description": "Pharmaceutical products"
    },
    "mainProcurementCategory": "goods"
  },
  "parties": [
    {
      "id": "GB-FTS-1383",
      "name": "Velindre NHS Trust, NHS Wales Shared Services Partnership — Procurement Services (on behalf of All Wales LHB's and Trusts)",
      "roles": [
        "buyer",
        "centralPurchasingBody"
      ],
      "address": {
        "region": "UKL",
        "locality": "Cardiff",
        "postalCode": "CF14 3UB",
        "countryName": "United Kingdom",
        "streetAddress": "Procurement Services, 4th Floor, Companies House, Crown Way"
      },
      "details": {
        "url": "https://etenderwales.bravosolution.co.uk/",
        "buyerProfile": "https://nwssp.nhs.wales/ourservices/procurement-services/",
        "classifications": [
          {
            "id": "BODY_PUBLIC",
            "scheme": "TED_CA_TYPE",
            "description": "Body governed by public law"
          },
          {
            "id": "07",
            "scheme": "COFOG",
            "description": "Health"
          }
        ]
      },
      "identifier": {
        "legalName": "Velindre NHS Trust, NHS Wales Shared Services Partnership — Procurement Services (on behalf of All Wales LHB's and Trusts)"
      },
      "contactPoint": {
        "email": "Theo.davies@wales.nhs.uk",
        "telephone": "+44 2920903883"
      }
    }
  ],
  "language": "en",
  "initiationType": "tender"
}